Major Depressive Disorder With Anxious Distress
3 clinical trials · Condition
◉ Watch Major Depressive Disorder With Anxious Distress
| Record | Firm | Date |
|---|---|---|
| An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study) (NCT07161700) | Seaport Therapeutics | 2025-09-02 |
| A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study) (NCT07065240) | Seaport Therapeutics | 2025-06-19 |
| A Study of JNJ-61393215 in the Treatment of Depression (NCT04080752) | Janssen Research & Development, LLC | 2019-09-17 |
Track Major Depressive Disorder With Anxious Distress automatically
Every clearance here is in the API, with alerts when new ones post.